BOULDER, Colo. -- (Business Wire)
The
Shuman Law Firm announces that it is investigating potential claims
against certain officers and directors of BioScrip, Inc. (“BioScrip” or
the “Company”) (Nasdaq: BIOS).
BioScrip is a New York-based company that provides home infusion and
other home care services, and pharmacy benefit management services in
the United States.
The Firm’s investigation relates to a U.S. Department of Justice Press
Release which disclosed that BioScrip has agreed to forfeit $15 million
for the Company’s participation in a kickback scheme with Novartis
Pharmaceuticals, Inc.
If you currently own BioScrip common stock and are interested in
discussing your rights, or have information relating to this
investigation, please contact Kip B. Shuman or Rusty E. Glenn toll-free
at 866-569-4531 or email Mr. Shuman at kip@shumanlawfirm.com
or email Mr. Glenn at rusty@shumanlawfirm.com.
The Shuman Law Firm represents investors throughout the nation,
concentrating its practice in stockholder litigation.
Contacts:
The Shuman Law Firm
Kip B. Shuman, Esq., 866-569-4531 or
303-861-3003
kip@shumanlawfirm.com
Rusty
E. Glenn, Esq., 866-569-4531 or 303-861-3003
rusty@shumanlawfirm.com
Fax:
303-536-7849
www.shumanlawfirm.com
Source: The Shuman Law Firm
© 2024 Canjex Publishing Ltd. All rights reserved.